Stem cells banish severe autoimmune disease for 15 years

Two individuals received a stem cell therapy for a severe autoimmune disease affecting the spinal cord and optic nerve, with the treatment demonstrating sustained remission for 15 years. This groundbreaking approach, detailed in a publication on June 19, 2026, involved hematopoietic stem cell transplantation (HSCT) to reset the immune system. The therapy targeted a condition that previously had limited treatment options and often led to progressive disability. The long-term success observed in these initial patients suggests a potential paradigm shift in managing certain aggressive autoimmune disorders. Researchers are now focused on understanding the precise mechanisms behind this prolonged immune tolerance and exploring the therapy's applicability to other autoimmune conditions. The study highlights the regenerative potential of stem cells in restoring immune homeostasis and preventing further tissue damage. This development offers significant hope for patients suffering from debilitating autoimmune diseases that have historically been challenging to treat effectively. The publication in Nature underscores the scientific rigor and potential impact of this innovative therapeutic strategy.